This compound is an active pharmaceutical ingredient with a salt-like structure, composed of a chiral azabicyclo-octane derivative and a phenyl-dihydroisoquinoline carboxylate moiety, combined with succinic acid. It is primarily used as a pharmaceutical raw material in research and manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 862207-70-3
Ethyl eicosapentaenoate
pharmaceutical raw material
Vaprisol
pharmaceutical raw material
Menatetrenone
pharmaceutical raw material
Azilsartan medoxomil
pharmaceutical raw material
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
pharmaceutical raw material
(1S,3S)-Solifenacin Hydrochloride
pharmaceutical raw material
Solifenacin
pharmaceutical raw material
Solifenacin succinate
pharmaceutical raw material
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1R)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;butanedioic acid
RXZMMZZRUPYENV-UMIAIAFLSA-N
C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O